ShareValue scores for HLTHQ: Valuation 50, Quality 50, Growth 0, Health 50.

HLTHQ
NASDAQ

Cue Health Inc.

$0.00
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 14%
Valuation
50
Fair Value
Price vs Value
Quality
50
Moderate
Business Strength
Growth
N/A
Weak
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
1
Bearish
Price Trend

Company Details

About

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California. On May 28, 2024, Cue Health Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Score Analysis

AI Investment Thesis

Data as of:Feb 21, 2026
|
Last calculated:Jul 10, 2026